Evaluation of corticospinal axon loss by fluorescent dye tracing in mice with experimental autoimmune encephalomyelitis

Journal of Neuroscience Methods

Volumn 167, Issue 2, 2008, Pages 191-197

  Liu, Zhongwu ^a   Li, Yi ^a   Zhang, Jing ^a   Elias, Stanton ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Axon loss; Corticospinal tract; DiI; Experimental autoimmune encephalomyelitis; Mice

Indexed keywords

1,1'' DIOLEYL 3,3,3'',3'' TETRAMETHYLINDOCARBOCYANINEMETHANESULFONATE; CARBOCYANINE; FLUORESCENT DYE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN MAPPING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; DISEASE SEVERITY; FEMALE; MOTOR CORTEX; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; PYRAMIDAL TRACT; SENSORIMOTOR CORTEX; SILVER STAINING; VOLUNTARY MOVEMENT;

AMINO ACIDS; ANIMALS; AXONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EVALUATION STUDIES AS TOPIC; FEMALE; FLUORESCENT DYES; MICE; PYRAMIDAL TRACTS;

EID: 36849027688     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.08.013     Document Type: Article

References (37)

1. Arnold D.L. Magnetic resonance spectroscopy: imaging axonal damage in MS. J Neuroimmunol 98 (1999) 2-6
2. Bechtold D.A., Miller S.J., Dawson A.C., Sun Y., Kapoor R., Berry D., et al. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol 253 (2006) 1542-1551
3. Bettelli E. Building different mouse models for human MS. Ann N Y Acad Sci 1103 (2007) 11-18
4. Bjartmar C., Kidd G., Mork S., Rudick R., and Trapp B.D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48 (2000) 893-901
5. Bjartmar C., Wujek J.R., and Trapp B.D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206 (2003) 165-171
6. Black J.A., Liu S., Hains B.C., Saab C.Y., and Waxman S.G. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 129 (2006) 3196-3208
7. Brown Jr. L.T. Projections and termination of the corticospinal tract in rodents. Exp Brain Res 13 (1971) 432-450
8. De Stefano N., Matthews P.M., Fu L., Narayanan S., Stanley J., Francis G.S., et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121 Pt 8 (1998) 1469-1477
9. DeLuca G.C., Ebers G.C., and Esiri M.M. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 127 (2004) 1009-1018
10. Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 120 Pt 3 (1997) 393-399
11. Filippi M., Bozzali M., Rovaris M., Gonen O., Kesavadas C., Ghezzi A., et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126 (2003) 433-437
12. Furlan R., Martino G., Galbiati F., Poliani P.L., Smiroldo S., Bergami A., et al. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol 163 (1999) 2403-2409
13. Gold R., Hartung H.P., and Toyka K.V. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 6 (2000) 88-91
14. Heffner R.S., and Masterton R.B. The role of the corticospinal tract in the evolution of human digital dexterity. Brain Behav Evol 23 (1983) 165-183
15. Hickey W.F. The pathology of multiple sclerosis: a historical perspective. J Neuroimmunol 98 (1999) 37-44
16. Kaneko S., Wang J., Kaneko M., Yiu G., Hurrell J.M., Chitnis T., et al. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J Neurosci 26 (2006) 9794-9804
17. Kerschensteiner M., Bareyre F.M., Buddeberg B.S., Merkler D., Stadelmann C., Bruck W., et al. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med 200 (2004) 1027-1038
18. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157 (2000) 267-276
19. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., and Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 (2002) 2202-2212
20. Litchfield S., and Nagy Z. New temperature modification makes the Bielschowsky silver stain reproducible. Acta Neuropathol (Berl) 101 (2001) 17-21
21. Mancardi G., Hart B., Roccatagliata L., Brok H., Giunti D., Bontrop R., et al. Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J Neurol Sci 184 (2001) 41-49
22. Matthews P.M., De Stefano N., Narayanan S., Francis G.S., Wolinsky J.S., Antel J.P., et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 18 (1998) 327-336
23. McGavern D.B., Murray P.D., Rivera-Quinones C., Schmelzer J.D., Low P.A., and Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 123 Pt 3 (2000) 519-531
24. Medana I.M., and Esiri M.M. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126 (2003) 515-530
25. Papadopoulos D., Pham-Dinh D., and Reynolds R. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp Neurol 197 (2006) 373-385
26. Paxinos G., and Franklin K. The mouse brain in stereotaxic coordinates (1997), Academic Press, San Diego
27. Pike G.B., de Stefano N., Narayanan S., Francis G.S., Antel J.P., and Arnold D.L. Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol 20 (1999) 829-837
28. Raine C.S., and Cross A.H. Axonal dystrophy as a consequence of long-term demyelination. Lab Invest 60 (1989) 714-725
29. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 (1998) 278-285
30. Trapp B.D., Ransohoff R., and Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 12 (1999) 295-302
31. Tsai E.C., van Bendegem R.L., Hwang S.W., and Tator C.H. A novel method for simultaneous anterograde and retrograde labeling of spinal cord motor tracts in the same animal. J Histochem Cytochem 49 (2001) 1111-1122
32. van Waesberghe J.H., Kamphorst W., De Groot C.J., van Walderveen M.A., Castelijns J.A., Ravid R., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46 (1999) 747-754
33. Vannucchi M.G., and Faussone-Pellegrini M.S. Synapse formation during neuron differentiation: an in situ study of the myenteric plexus during murine embryonic life. J Comp Neurol 425 (2000) 369-381
34. Wujek J.R., Bjartmar C., Richer E., Ransohoff R.M., Yu M., Tuohy V.K., et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 61 (2002) 23-32
35. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
36. Zhang J., Li Y., Cui Y., Chen J., Lu M., Elias S.B., et al. Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res 1034 (2005) 34-39
37. Zhang J., Li Y., Lu M., Cui Y., Chen J., Noffsinger L., et al. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 84 (2006) 587-595